2. Signaling Pathways
  3. Epigenetics
  4. Histone Methyltransferase
  5. SMYD3 Isoform

SMYD3

 

SMYD3 Related Products (7):

Cat. No. Product Name Effect Purity
  • HY-21972
    BCI-121
    		Inhibitor 99.26%
    BCI-121 is a SMYD3 inhibitor that impairs the proliferation of cancer cell.
  • HY-19324
    EPZ031686
    		Inhibitor 99.71%
    EPZ031686 is an potent and orally active SMYD3 inhibitor and with an IC50 value of 3 nM. EPZ031686 can be used for cancer research.
  • HY-104009A
    GSK2807 Trifluoroacetate
    		Inhibitor 99.36%
    GSK2807 Trifluoroacetate is a potent, selective and SAM-competitive inhibitor of SMYD3, with a Ki of 14 nM and an IC50 of 130 nM.
  • HY-112080
    BAY-6035
    		Inhibitor 99.82%
    BAY-6035 is a potent, selective and substrate-competitive inhibitor of SMYD3. BAY-6035 inhibits methylation of MEKK2 peptide with an IC50 of 88 nM.
  • HY-151379
    EM127
    		Inhibitor 98.37%
    EM127 (compound 11c) is a SMYD3 covalent inhibitor with high selectivity, high affinity (KD=13 μM) and site-specificity. EM127 effectively inhibits ERK1/2 phosphorylation and reduces transcriptional regulation of SMYD3 target genes. EM127 effectively and prolongedly impairs methyltransferase activity. EM127 can be used in cancer research, particularly in SMYD3 positive tumours.
  • HY-128352
    SMYD3-IN-1
    		Inhibitor 98.01%
    SMYD3-IN-1 (compound 29) is an irreversible and selective inhibitor of SMYD3 (SET and MYND domain containing 3), with an IC50 of 11.7 nM.
  • HY-152228
    SMYD3-IN-2
    		Inhibitor
    SMYD3-IN-2 is a SMYD3 inhibitor against gastric cancer via inducing lethal autophagy. SMYD3-IN-2 has inhibitory for SMYD3 and BGC823 cells with IC50 values of 0.81 μM and 0.75 μM, respectively. SMYD3-IN-2 can be used for the research of cancer.